Tango Therapeutics TNGX
NASDAQ TNGX
$24.95 +0.53 (+2.17%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Total Non-Current Liabilities (2020)

Updated

Tango Therapeutics (TNGX) recorded Total Non-Current Liabilities of $168.65 million in Q4 2020, up 45.8% from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Total Non-Current Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Tango Therapeutics 4.20 Bn 2.31 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 168.65 Mn
Sep 30, 2020 115.64 Mn
API Access

Tango Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TNGX&period=max&api_key=YOUR_API_KEY